Illumina 2026-02-08 Assessing Illumina (ILMN) Valuation After Recent Share Price Weakness And Mixed Long Term Returns - simplywall.st
Lonza News 2026-02-08 Lonza’s Strategic Pivot Fuels Robust Growth and Shareholder Returns - AD HOC NEWS
Endpoints News 2026-02-07 #ACTRIMS26: Sanofi unpacks data from a failed Phase 3 tolebrutinib trial in PPMS
Thermo Fisher 2026-02-07 Taking A Fresh Look At Thermo Fisher Scientific (TMO) Valuation After Recent Share Price Weakness - simplywall.st
Agilent 2026-02-07 Agilent’s SLAS2026 Automation Push Might Change The Case For Investing In Agilent Technologies (A) - simplywall.st
Endpoints News 2026-02-07 The Hims vs. Novo showdown; Pfizer’s monthly GLP-1 data; Q4 earnings roundup; and more
Illumina 2026-02-07 Illumina (ILMN) One Off Gain Shapes Profitability Narrative After FY 2025 Earnings - simplywall.st
Illumina 2026-02-06 Key facts: Illumina Q4 2025 revenue rises to $1.16B; 2026 growth forecasted - TradingView
FierceBiotech 2026-02-06 UniQure pauses Fabry gene therapy dosing in 2 groups after toxicities emerge
BioPharma Dive 2026-02-06 White House’s online service for drug sales debuts with limited impact on prices